MENU

Alexium International Group Ltd: A promising small-cap?

Alexium International Group Ltd (ASX: AJX) is a small-cap company that designs and produces chemical treatments for textiles and sells them worldwide. It’s got patents and patent applications on 25 different chemical solutions and has been growing rapidly.

Here are some key stats:

  • $160 million market capitalisation
  • ~A$16m in revenues (last 9 months)
  • Burning $5m cash per quarter but expected to hit break-even in current quarter
  • $6.4m cash at bank at 31 March 2017
  • Proprietary patents for flame-retardant equipment plus solutions for moisture wicking, antimicrobial, water repellent solutions, and more

Management states they now earn $2 million in recurring revenues each month from existing customers, which suggests the company is priced at about 7x annual sales. The total target market across Alexium’s products is estimated in multiple billions and includes most textiles (bedding fabric, sportswear, uniforms, etc) and a variety of other surfaces.

With a low-cost method of application and the recent strong growth in sales, the company has been able to achieve benefits of scale and appears close to a tipping point where it can become cash flow positive and start doing profitable business. Sales are reportedly growing via both winning new customers and increasing sales to current customers.

The company is an interesting prospect but my chief concern is over its cash flows. Depending on sales growth, the company really only has enough cash to continue operating for the current quarter, and it’s had to borrow ~$7 million at 15% per annum to pay for working capital requirements.

While this could be a positive, in that debt can be paid down and is not dilutive like a capital raising, any sort of unforeseen issue could see Alexium having to raise capital anyway. As a result I’ll remain on the sideline for the time being.

Instead, readers could consider these 3 promising growth businesses:

Top 3 ASX Blue Chips To Buy In 2017

For many, blue chip stocks mean stability, profitability and regular dividends, often fully franked..

But knowing which blue chips to buy, and when, can be fraught with danger.

The Motley Fool's in-house analyst team has poured over thousands of hours worth of proprietary research to bring you the names of "The Motley Fool's Top 3 Blue Chip Stocks for 2017."

Each one pays a fully franked dividend. Each one has not only grown its profits, but has also grown its dividend. One increased it by a whopping 33%, while another trades on a grossed up (fully franked) dividend yield of almost 7%.

The names of these Top 3 ASX Blue Chips are included in this specially prepared free report. But you will have to hurry. Depending on demand - and how quickly the share prices of these companies moves - we may be forced to remove this report.

Click here to claim your free report.

Motley Fool contributor Sean O'Neill has no position in any stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

Two New Stock Picks Every Month!

Not to alarm you, but you’re about to miss a very important event! Chief Investment Advisor Scott Phillips and his team at Motley Fool Share Advisor are about to reveal their latest official stock recommendation. The premium “buy alert” will be unveiled to members and you can be among the first to act on the tip.

Don’t let this opportunity pass you by – this is your chance to get in early!

Simply enter your email now to find out how you can get instant access.

By clicking this button, you agree to our Terms of Service and Privacy Policy. We will use your email address only to keep you informed about updates to our website and about other products and services we think might interest you. You can unsubscribe from Take Stock at anytime. Please refer to our Financial Services Guide (FSG) for more information.